@cottonelucia.bsky.social
🚨 We’re hiring a Postdoc!
Join our osteosarcoma research project @mariasecrier.bsky.social @fionafreeman.bsky.social. Funded by @littleprincesses.bsky.social 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
Join our osteosarcoma research project @mariasecrier.bsky.social @fionafreeman.bsky.social. Funded by @littleprincesses.bsky.social 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
UCL – University College London
UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).
bit.ly
June 9, 2025 at 10:18 PM
🚨 We’re hiring a Postdoc!
Join our osteosarcoma research project @mariasecrier.bsky.social @fionafreeman.bsky.social. Funded by @littleprincesses.bsky.social 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
Join our osteosarcoma research project @mariasecrier.bsky.social @fionafreeman.bsky.social. Funded by @littleprincesses.bsky.social 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
Reposted
📣We’re hiring a Postdoc!
Join my new lab at the University of Oxford to investigate therapy resistance in brain cancer.
⏰Deadline: 16 June 2025
Apply 👇
my.corehr.com/pls/uoxrecru...
Boosts appreciated!
#PostdocJobs #CancerResearch #BrainCancer
Join my new lab at the University of Oxford to investigate therapy resistance in brain cancer.
⏰Deadline: 16 June 2025
Apply 👇
my.corehr.com/pls/uoxrecru...
Boosts appreciated!
#PostdocJobs #CancerResearch #BrainCancer
https://my.corehr.com/pls/uoxrecruit…
May 19, 2025 at 3:03 PM
📣We’re hiring a Postdoc!
Join my new lab at the University of Oxford to investigate therapy resistance in brain cancer.
⏰Deadline: 16 June 2025
Apply 👇
my.corehr.com/pls/uoxrecru...
Boosts appreciated!
#PostdocJobs #CancerResearch #BrainCancer
Join my new lab at the University of Oxford to investigate therapy resistance in brain cancer.
⏰Deadline: 16 June 2025
Apply 👇
my.corehr.com/pls/uoxrecru...
Boosts appreciated!
#PostdocJobs #CancerResearch #BrainCancer
🚨 We’re hiring a Postdoc!
Join our osteosarcoma research project with @secrierlab + @freemanfiona, funded by @LPTrustUK 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
Join our osteosarcoma research project with @secrierlab + @freemanfiona, funded by @LPTrustUK 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
UCL – University College London
UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).
bit.ly
June 9, 2025 at 10:16 PM
🚨 We’re hiring a Postdoc!
Join our osteosarcoma research project with @secrierlab + @freemanfiona, funded by @LPTrustUK 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
Join our osteosarcoma research project with @secrierlab + @freemanfiona, funded by @LPTrustUK 🧬🧫
🔹Cellular & molecular biology
🔹Cool 3D models
📍 UCL Cancer Institute, London
🗓️ July 1
📎 bit.ly/4kBCPt3
🌐 More info: lnkd.in/eahvf7Tg
New Preprint Alert! 🚨 Targeting Metabolic Stress in Chordoma - with @AdamCribbs
Could glutamyl-prolyl-tRNA synthetase (EPRS) inhibition be a new therapeutic avenue for #chordoma?
Read our preprint here: www.biorxiv.org/content/10.1...
Could glutamyl-prolyl-tRNA synthetase (EPRS) inhibition be a new therapeutic avenue for #chordoma?
Read our preprint here: www.biorxiv.org/content/10.1...
ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma
Chordoma, a rare primary bone malignancy, currently lacks effective targeted therapies. Despite surgical resection and adjuvant radiotherapy, prognosis remains poor. Recent preclinical studies have hi...
www.biorxiv.org
March 16, 2025 at 11:37 AM
New Preprint Alert! 🚨 Targeting Metabolic Stress in Chordoma - with @AdamCribbs
Could glutamyl-prolyl-tRNA synthetase (EPRS) inhibition be a new therapeutic avenue for #chordoma?
Read our preprint here: www.biorxiv.org/content/10.1...
Could glutamyl-prolyl-tRNA synthetase (EPRS) inhibition be a new therapeutic avenue for #chordoma?
Read our preprint here: www.biorxiv.org/content/10.1...